Literature DB >> 3678144

Androgen dependence of growth and epithelial morphogenesis in neonatal mouse bulbourethral glands.

P S Cooke1, P F Young, G R Cunha.   

Abstract

The early development of the mouse bulbourethral gland (BUG) and the role of testosterone (T) in the normal growth and epithelial morphogenesis of this male accessory sex gland were examined. The mouse BUG differentiates from the urogenital sinus on day 17 of gestation (vaginal plug = day 0; birth = day 19), and initially consists of a solid epithelial rudiment encased in a large condensed capsular mesenchyme. The epithelium begins to branch and canalize on day 1 postnatally, and the branches enlarge and become more numerous on days 2 and 3. On day 4, secondary branches appear, and by day 6, the epithelium has become extensively arborized and almost fills the mesenchymal capsule. The BUG increases 3.9-fold in DNA content from day 0 (day of birth) to day 6 postnatally; the epithelium grows proportionately more than the mesenchyme during this period (12-fold vs. 2.3-fold). Growth of BUGs in mice castrated at birth or castrated and then treated with cyproterone acetate, an antiandrogen, over the first 6 days of life was reduced by 80%, but not abolished. Thus, the growth of the BUG is partially independent of androgens during early neonatal life. However, morphogenesis of the BUG epithelium is totally abolished in neonatally castrated mice. T replacement given to neonatally castrated mice during days 0-6 restored development to normal. T injections also reinitiated growth and morphogenesis in developmentally retarded BUGs from 6-day-old neonatally castrated mice. The partial dependence of the neonatal BUG on androgens for growth is similar to that seen in the prostate, which is also derived from the urogenital sinus. In contrast to the prostate, where neonatal castration reduces but does not abolish epithelial morphogenesis, androgen deprivation completely abolished epithelial morphogenesis in the neonatal BUG. (Endocrinology 121: 2153-2160, 1987).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678144     DOI: 10.1210/endo-121-6-2153

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Roles for Nkx3.1 in prostate development and cancer.

Authors:  R Bhatia-Gaur; A A Donjacour; P J Sciavolino; M Kim; N Desai; P Young; C R Norton; T Gridley; R D Cardiff; G R Cunha; C Abate-Shen; M M Shen
Journal:  Genes Dev       Date:  1999-04-15       Impact factor: 11.361

2.  Essential roles of androgen signaling in Wolffian duct stabilization and epididymal cell differentiation.

Authors:  Aki Murashima; Shinichi Miyagawa; Yukiko Ogino; Hisayo Nishida-Fukuda; Kimi Araki; Takahiro Matsumoto; Takehito Kaneko; Kazuya Yoshinaga; Ken-ichi Yamamura; Takeshi Kurita; Shigeaki Kato; Anne M Moon; Gen Yamada
Journal:  Endocrinology       Date:  2011-02-08       Impact factor: 4.736

3.  Transforming growth factor-beta 2 heterozygous mutant mice exhibit Cowper's gland hyperplasia and cystic dilations of the gland ducts (Cowper's syringoceles).

Authors:  Nicole Dünker; Gerhard Aumüller
Journal:  J Anat       Date:  2002-08       Impact factor: 2.610

4.  Genome-wide analysis of androgen receptor binding and transcriptomic analysis in mesenchymal subsets during prostate development.

Authors:  Claire Nash; Nadia Boufaied; Dunarel Badescu; Yu Chang Wang; Miltiadis Paliouras; Mark Trifiro; Ioannis Ragoussis; Axel A Thomson
Journal:  Dis Model Mech       Date:  2019-07-25       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.